Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors
Clinical trial NCT02500199 · UNKNOWN
Trial details
- NCT number
- NCT02500199
- Sponsor
- Hengrui Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2021-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.